Funding
capacura investment · Healthtech

TimeTeller secures investment from capacura

The investor backs saliva-based circadian diagnostics.

By RoundOS Funding desk

TimeTeller secured backing from capacura in an investment announced on August 18, 2025. The amount was kept confidential. The investment formed part of a wider financing round that was still in progress at the time.

The Hamburg company develops saliva-based diagnostics for measuring a person’s circadian rhythm. The financing supports market introduction of the technology, which grew out of research at Charité in Berlin.

Use of funds

Support market introduction of circadian diagnostics.

Funding history

capacura investment · This roundUndisclosed
Women TechEU grant€75KGründungspreis+ prize€32KFemale StartAperitivo national prize€5KFemale StartAperitivo regional prize€500InnoRampUp grant€150K

Sources

  1. capacura invests in TimeTellerstartupcity.hamburg · Aug 18, 2025
  2. Financing announcementcapacura.de

Similar rounds

All Healthtech rounds →
Esonitro

Esonitro develops flexible neural electrodes and brain-computer interface technology, including its movable NeuroWorm electrode.

~CN¥100MAngel+ · Nov 2, 2026
OBSESS

OBSESS connects people with sports venues, gyms, trainers, nutrition providers and fitness brands through a shared digital marketplace.

~₹30MAngel · Nov 2, 2026
Atomic Software

Atomic Software develops industry-specific business software, including the medicalforce platform for clinic operations.

¥600MSeries C · Nov 2, 2026
nPhase

nPhase provides software that connects clinical research data from collection through statistical analysis and regulatory submission.

$30MSeries D · Nov 2, 2026

Related